TY - GEN
T1 - Role of osteopontin in early brain injury after subarachnoid hemorrhage in rats
AU - Suzuki, Hidenori
AU - Ayer, Robert
AU - Sugawara, Takashi
AU - Chen, Wanqiu
AU - Sozen, Takumi
AU - Hasegawa, Yu
AU - Kanamaru, Kenji
AU - Zhang, John H.
N1 - Funding Information:
This study was partially supported by grants (NS053407) from the National Institutes of Health to J.H.Z.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Background: Subarachnoid hemorrhage (SAH)-induced early brain injury (EBI) contributes to delayed ischemic neurological deficits, one of whose key pathologic manifestation is the blood-brain barrier (BBB) disruption. Although post-SAH BBB breakdown is a self-repairable phenomenon, the molecular pathways are unknown. We determined the role of osteopontin (OPN), a pleiotropic extracellular matrix glycoprotein, in the post-SAH BBB disruption in rats. Method: First, we produced the endovascular perforation model of SAH and studied if OPN is induced in the brain after SAH. Secondly, we examined the effects of blockage of endogenous OPN induction on neurological impairments and BBB disruption. Thirdly, we evaluated the effects of exogenous OPN on neurological impairments, brain edema and BBB disruption, and the related protein expression levels. Findings: OPN was significantly induced and peaked at 72h after SAH, in the recovery phase of EBI. OPN small interfering RNA significantly aggravated neurological impairment and BBB disruption 72h after SAH. Exogenous OPN significantly prevented neurological impairment, brain edema and BBB disruption associated with the deactivation of nuclear factor-κB activity, the inhibition of matrix metalloproteinase (MMP)-9 induction and tissue inhibitor of MMP-1 reduction, and the consequent preservation of cerebral microvessel basal lamina protein laminin and tight junction protein zona occludens-1. Conclusions: These findings suggest the protective effects of OPN against BBB disruption after SAH, a finding which should provide a novel therapeutic approach for post-SAH EBI. © 2011 Springer-Verlag/Wien.
AB - Background: Subarachnoid hemorrhage (SAH)-induced early brain injury (EBI) contributes to delayed ischemic neurological deficits, one of whose key pathologic manifestation is the blood-brain barrier (BBB) disruption. Although post-SAH BBB breakdown is a self-repairable phenomenon, the molecular pathways are unknown. We determined the role of osteopontin (OPN), a pleiotropic extracellular matrix glycoprotein, in the post-SAH BBB disruption in rats. Method: First, we produced the endovascular perforation model of SAH and studied if OPN is induced in the brain after SAH. Secondly, we examined the effects of blockage of endogenous OPN induction on neurological impairments and BBB disruption. Thirdly, we evaluated the effects of exogenous OPN on neurological impairments, brain edema and BBB disruption, and the related protein expression levels. Findings: OPN was significantly induced and peaked at 72h after SAH, in the recovery phase of EBI. OPN small interfering RNA significantly aggravated neurological impairment and BBB disruption 72h after SAH. Exogenous OPN significantly prevented neurological impairment, brain edema and BBB disruption associated with the deactivation of nuclear factor-κB activity, the inhibition of matrix metalloproteinase (MMP)-9 induction and tissue inhibitor of MMP-1 reduction, and the consequent preservation of cerebral microvessel basal lamina protein laminin and tight junction protein zona occludens-1. Conclusions: These findings suggest the protective effects of OPN against BBB disruption after SAH, a finding which should provide a novel therapeutic approach for post-SAH EBI. © 2011 Springer-Verlag/Wien.
KW - Blood-brain barrier
KW - Brain injury
KW - Osteopontin
KW - Subarachnoid hemorrhage
KW - Severity of Illness Index
KW - Rats
KW - Male
KW - Functional Laterality
KW - Brain Injuries/etiology
KW - Rats, Sprague-Dawley
KW - Injections, Intraventricular/methods
KW - Brain/drug effects
KW - Osteopontin/metabolism
KW - Subarachnoid Hemorrhage/complications
KW - Animals
KW - Analysis of Variance
KW - Time Factors
KW - Blood-Brain Barrier/drug effects
KW - Models, Biological
KW - RNA, Small Interfering/pharmacology
KW - Gene Expression Regulation/drug effects
KW - Disease Models, Animal
UR - https://www.scopus.com/pages/publications/85052609988
UR - https://www.scopus.com/pages/publications/85052609988#tab=citedBy
UR - https://www.mendeley.com/catalogue/a2394b93-a520-35ca-b229-f88c20a7fc66/
U2 - 10.1007/978-3-7091-0353-1_14
DO - 10.1007/978-3-7091-0353-1_14
M3 - Conference contribution
C2 - 21116919
SN - 9783709103524
SN - 978-3-7091-1658-6
T3 - Acta Neurochirurgica, Supplementum
SP - 75
EP - 79
BT - Early Brain Injury or Cerebral Vasospasm
PB - Springer Vienna
ER -